Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Quan Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6252-0154; OpenAlex author ID A5082854198, A5102361137. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer. Co-author DOI 10.1038/s41467-026-75132-3↗
  2. Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2021.121176↗
  3. Excipient-free nanodispersion of 7-ethyl-10-hydroxycamptothecin exerts potent therapeutic effects against pancreatic cancer cell lines and patient-derived xeno… Co-author DOI 10.1016/j.canlet.2019.08.019↗
  4. Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistance. Co-author DOI 10.1016/j.biomaterials.2017.08.002↗
  5. GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment. Co-author DOI 10.1038/s41598-017-13869-0↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Youqing Shen · 4 shared papers, 2017–2021 · strength 0.36
  2. Xiangrui Liu · 3 shared papers, 2017–2021 · strength 0.28
  3. Xuan Zhou · 1 shared paper, 2026 · strength 0.21
  4. Min Li · 1 shared paper, 2026 · strength 0.21
  5. Bo Wang · 1 shared paper, 2026 · strength 0.21
  6. Xiaofan Guo · 1 shared paper, 2026 · strength 0.21
  7. Tianxing Zhou · 1 shared paper, 2026 · strength 0.21
  8. Yu Wang · 1 shared paper, 2026 · strength 0.21
  9. Jihui Hao · 1 shared paper, 2026 · strength 0.21
  10. Lei Zheng · 1 shared paper, 2026 · strength 0.21
  11. Mien‐Chie Hung · 1 shared paper, 2026 · strength 0.21
  12. Liying Wang · 2 shared papers, 2017–2021 · strength 0.18
  13. Weilin Wang · 2 shared papers, 2017–2019 · strength 0.14
  14. Xiangsheng Liu · 1 shared paper, 2021 · strength 0.12
  15. Haiping Jiang · 1 shared paper, 2021 · strength 0.12
  16. Liping Cao · 1 shared paper, 2021 · strength 0.12
  17. Huan Meng · 1 shared paper, 2021 · strength 0.12
  18. Hao Xu · 1 shared paper, 2019 · strength 0.08
  19. Linshi Zhang · 1 shared paper, 2019 · strength 0.08
  20. Rong Du · 1 shared paper, 2019 · strength 0.08
  21. Yuan Ding · 1 shared paper, 2019 · strength 0.08
  22. Jiarong Zhou · 1 shared paper, 2019 · strength 0.08
  23. Huilin Zheng · 1 shared paper, 2019 · strength 0.08
  24. Zipeng Lu · 1 shared paper, 2017 · strength 0.06
  25. Yi Miao · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.